Relieves discomfort associated with acute, painful musculoskeletal conditions. Sold as Soma, Rela. Every FDA application for this active ingredient: 2 branded and 24 generic.
As of Nov 16, 2026, FDA lists 26 applications for Carisoprodol (sold as Soma, Rela), first approved Apr 9, 1959, with 1 new use approved and 0 published complete response letters.
| Carisoprodol | Part D | $4.0M | -6% | 60,014 |
| Soma | Part D | $1.4M | -7% | 225 |
| Apr 9, 1959 | SomaNDA 11792 · New molecular entity | Mylan Speciality LP | 27 | Marketed |
| Jun 12, 1979 | CarisoprodolANDA 86179 | Watson Labs Teva | 19 | Discontinued |
| Apr 20, 1982 | CarisoprodolANDA 87499 | Watson Labs | 27 | Marketed |
| Apr 13, 1989 | CarisoprodolANDA 81025 | Pharmazone | 16 | Marketed |
| Oct 17, 1991 | CarisoprodolANDA 89346 | Sun Pharm Industries | 22 | Discontinued |
| Jan 24, 1996 | CarisoprodolANDA 40124 | Hikma | 15 | Discontinued |
| Dec 3, 1996 | CarisoprodolANDA 40152 | Watson Labs | 3 | Discontinued |
| Mar 7, 1997 | CarisoprodolANDA 40188 | Oxford Pharms | 1 | Marketed |
| Sep 8, 1997 | CarisoprodolANDA 40245 | Chartwell Rx | 4 | Marketed |
| Sep 21, 2000 | CarisoprodolANDA 40397 | Epic Pharma LLC | 6 | Discontinued |
| Jun 21, 2001 | CarisoprodolANDA 40421 | Able | 1 | Discontinued |
| Jun 7, 2005 | CarisoprodolANDA 40576 | Accelrx Labs | 0 | Marketed |
| Feb 27, 2007 | CarisoprodolANDA 40755 | Sun Pharm Inds Ltd | 2 | Discontinued |
| Oct 22, 2008 | CarisoprodolANDA 40823 | Ingenus Pharms LLC | 2 | Marketed |
| Aug 6, 2009 | CarisoprodolANDA 40792 | Aurobindo Pharma | 7 | Marketed |
| Jan 27, 2014 | CarisoprodolANDA 203374 | Sciegen Pharms | 1 | Marketed |
| Oct 27, 2014 | CarisoprodolANDA 205085 | Orient Pharma Co Ltd | 1 | Marketed |
| Oct 28, 2014 | CarisoprodolANDA 90988 | Natco | 0 | Marketed |
| Jul 8, 2015 | CarisoprodolANDA 205126 | Heritage | 3 | Marketed |
| Nov 12, 2015 | CarisoprodolANDA 205513 | Strides Pharma | 0 | Discontinued |
| May 11, 2017 | CarisoprodolANDA 207237 | Mpp Pharma | 1 | Marketed |
| Oct 20, 2021 | CarisoprodolANDA 211789 | Pharmazone | 0 | Marketed |
| — | CarisoprodolANDA 85433 | Watson Labs | 0 | Discontinued |
| — | CarisoprodolANDA 89390 | Pioneer Pharms | 0 | Discontinued |
| — | CarisoprodolANDA 89566 | Sandoz | 0 | Discontinued |
| — | RelaNDA 12155 | Schering | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA